Amrutanjan Ebitda from 2010 to 2024

AMRUTANJAN   716.45  2.70  0.38%   
Amrutanjan Health EBITDA yearly trend continues to be very stable with very little volatility. EBITDA is likely to drop to about 411.6 M. During the period from 2010 to 2024, Amrutanjan Health EBITDA quarterly data regression pattern had sample variance of 56408.7 T and median of  373,986,000. View All Fundamentals
 
EBITDA  
First Reported
2012-06-30
Previous Quarter
80 M
Current Value
176.5 M
Quarterly Volatility
83 M
 
Yuan Drop
 
Covid
Check Amrutanjan Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amrutanjan Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 35.2 M, Interest Expense of 2.4 M or Total Revenue of 2.3 B, as well as many indicators such as . Amrutanjan financial statements analysis is a perfect complement when working with Amrutanjan Health Valuation or Volatility modules.
  
This module can also supplement various Amrutanjan Health Technical models . Check out the analysis of Amrutanjan Health Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Amrutanjan Stock

Amrutanjan Health financial ratios help investors to determine whether Amrutanjan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amrutanjan with respect to the benefits of owning Amrutanjan Health security.